Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Unrecorded Unconditional Purchase Obligation, to be Paid, Year One

2.7 / 5 stars · 63/118 Roast Me

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Unrecorded Unconditional Purchase Obligation, to be Paid, Year One

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Unrecorded Unconditional Purchase Obligation, to be Paid, Year One of $166.08 million as of 2020-12-26, per its 10-K filed 2021-02-17.

Discontinued › Notes › Commitment and Contingencies

us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary · last filed 2021-02-17

  • 2020-12-26: Unrecorded Unconditional Purchase Obligation, to be Paid, Year One $166.08M.
  • 2019-12-28: Unrecorded Unconditional Purchase Obligation, to be Paid, Year One $106.10M.
Period endUnrecorded Unconditional Purchase Obligation, to be Paid, Year One
2020-12-26$166.08M
10-K · filed 2021-02-17
2019-12-28$106.10M
10-K · filed 2020-02-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71